Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al.
Loading...
Date
2012
Journal Title
Journal ISSN
Volume Title
Publisher
Lippincott Williams & Wilkins.
Abstract
No abstract available.
Description
Keywords
Clinical trials--Evaluation., HIV infections--Treatment., HIV infections--Drug therapy., Patient compliance.
Citation
Grobler, A., Abdool Karim, S.S. 2012. Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial: response to O’Hagan et al. AIDS 26 (17) p.2261.